IMBA-Senior Group Leader Daniel Gerlich elected new EMBO member
June 16, 2017
Vienna, 16 June 2017 – As EMBO announced today, Daniel Gerlich – senior group leader at IMBA – was elected to its membership, joining a group of more than 1700 of the best researchers in Europe and around the world.
65 new EMBO members in 2017
“Election to the EMBO Membership is recognition of research excellence, and I am pleased to welcome so many great scientists to our organisation,” says EMBO Director Maria Leptin.
In total 65 new members were elected- including 56 EMBO Members residing in 19 Member States of the European Molecular Biology Conference (EMBC) and nine EMBO Associate Members currently working in the USA and Japan.
A third of IMBA´s faculty are full EMBO members
Newly elected EMBO member Daniel Gerlich graduated with honors from the University of Freiburg, and earned his PhD in Biology from the University of Heidelberg in 2002, working in the group of Roland Eils. After postdoctoral research in Jan Ellenberg's laboratory at the European Molecular Biology Laboratory (EMBL) Heidelberg, he established his own laboratory in 2005 as Assistant Professor at the Institute of Biochemistry at ETH Zurich. In 2012, he moved to the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) in Vienna to take a position as senior research group leader. His research focuses on cell division, chromosome biology, and computer vision/machine learning methods for cell biology. Dr. Gerlich received several honors for his work, including a European Young Investigator Award of the European Research Council (2005), an ERC starting grant (2012), and election to the EMBO Young Investigator Program (2009).
Apart from Daniel Gerlich, Josef Penninger, Jürgen Knoblich, Julius Brennecke are full EMBO Members, Stefan Ameres and Kikuë Tachibana-Konwalski were recently elected as EMBO Young Investigators. An online directory with all existing and new EMBO Members is available at people.embo.org.
IMBA - Institute of Molecular Biotechnology is one of the leading biomedical research institutes in Europe focusing on cutting-edge functional genomics and stem cell technologies. IMBA is located at the Vienna Biocenter, the vibrant cluster of universities, research institutes and biotech companies in Austria. IMBA is a subsidiary of the Austrian Academy of Sciences, the leading national sponsor of non-university academic research.
EMBO is an organization of more than 1700 leading researchers that promotes excellence in the life sciences. The major goals of the organization are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, and help build a European research environment where scientists can achieve their best work. For more information: www.embo.org